Pertuzumab/Trastuzumab/Docetaxel Followed by FEC Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of pertuzumab, trastuzumab and docetaxel, followed by fluorouracil, epirubicin and intravenous cyclophosphamide, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.

**Synonyms:** - Pertuzumab + Trastuzumab + Docetaxel Followed by FEC - Pertuzumab + Trastuzumab + Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide - Pertuzumab-Trastuzumab-Docetaxel Followed by Fluorouracil-Epirubicin-Cyclophosphamide - Pertuzumab/Trastuzumab/Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide